This company has been marked as potentially delisted and may not be actively trading. UNITY Biotechnology (UBX) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsBuy This Stock UNITY Biotechnology Short Interest DataUNITY Biotechnology (UBX) has a short interest of 41,000 shares, representing 0.25% of the float (the number of shares available for trading by the public). This marks a -92.84% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 284,137 shares to cover all short positions.Current Short Interest41,000 sharesPrevious Short Interest572,500 sharesChange Vs. Previous Month-92.84%Dollar Volume Sold Short$15.75 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJune 30, 2025Outstanding Shares17,212,000 sharesShort Percent of Float0.25%Today's Trading Volume3,732,988 sharesAverage Trading Volume284,137 sharesToday's Volume Vs. Average1,314% Short Selling UNITY Biotechnology? Sign up to receive the latest short interest report for UNITY Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartUBX Short Interest Over TimeUBX Days to Cover Over TimeUBX Percentage of Float Shorted Over Time UNITY Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/202541,000 shares $15.75 thousand -92.8%0.3%0.1 $0.38 6/15/2025572,500 shares $456.86 thousand -34.4%3.7%1.9 $0.80 5/31/2025873,200 shares $593.78 thousand +16.6%5.6%3 $0.68 5/15/2025749,100 shares $570.07 thousand -11.7%4.8%4.4 $0.76 4/30/2025848,700 shares $959.03 thousand +12.9%5.5%5.2 $1.13 4/15/2025751,600 shares $729.05 thousand +6.6%4.8%3.6 $0.97 3/31/2025704,800 shares $732.99 thousand +10.1%4.6%2.6 $1.04 3/15/2025639,900 shares $1.13 million +15.3%4.2%2.4 $1.77 2/28/2025554,900 shares $948.88 thousand +7.5%3.6%2.3 $1.71 2/15/2025516,300 shares $1.13 million +12.1%3.4%2.2 $2.19 Get the Latest News and Ratings for UBX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for UNITY Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 1/31/2025460,400 shares $1.02 million +107.1%3.0%2 $2.22 1/15/2025222,300 shares $375.69 thousand -8.9%1.5%1.1 $1.69 12/31/2024244,000 shares $238.24 thousand -0.9%1.6%1.9 $0.98 12/15/2024246,100 shares $275.63 thousand -4.8%1.6%3.6 $1.12 11/30/2024258,400 shares $320.42 thousand -10.2%1.7%4.6 $1.24 11/15/2024287,600 shares $348.00 thousand -5.1%1.9%5.7 $1.21 10/31/2024303,000 shares $412.08 thousand -0.9%2.0%6.2 $1.36 10/15/2024305,700 shares $427.98 thousand -1.6%2.0%7.5 $1.40 9/30/2024310,700 shares $456.73 thousand +3.0%2.0%7.9 $1.47 9/15/2024301,800 shares $434.59 thousand -8.9%2.0%7.4 $1.44 8/31/2024331,200 shares $539.86 thousand +3.7%2.2%6.5 $1.63 8/15/2024319,500 shares $450.50 thousand +5.5%2.1%5.7 $1.41 7/31/2024303,000 shares $463.59 thousand -2.3%2.0%5.4 $1.53 7/15/2024310,100 shares $483.76 thousand -3.8%2.0%5.4 $1.56 6/30/2024322,200 shares $434.97 thousand 0.0%2.1%5.4 $1.35 6/15/2024322,300 shares $460.89 thousand -3.0%2.1%5.1 $1.43 5/31/2024332,400 shares $515.22 thousand +7.1%2.2%5.5 $1.55 5/15/2024310,300 shares $474.76 thousand -6.1%2.0%3.7 $1.53 4/30/2024330,400 shares $508.82 thousand +8.4%2.2%3.8 $1.54 4/15/2024304,800 shares $457.20 thousand -0.8%2.0%3.4 $1.50 3/31/2024307,200 shares $503.81 thousand +5.4%2.0%3.4 $1.64 3/15/2024291,600 shares $437.40 thousand +0.3%1.9%2.7 $1.50 2/29/2024290,600 shares $531.80 thousand -9.2%1.9%2.6 $1.83 2/15/2024320,000 shares $636.80 thousand +4.5%2.1%3.4 $1.99 1/31/2024306,100 shares $529.55 thousand -0.3%2.0%3.1 $1.73 1/15/2024307,100 shares $571.21 thousand -21.4%2.0%3.2 $1.86 12/31/2023390,700 shares $754.05 thousand -15.6%N/A0 $1.93 12/15/2023463,100 shares $791.90 thousand -7.7%3.1%5.5 $1.71 11/30/2023501,900 shares $963.65 thousand -12.3%3.8%6.9 $1.92 11/15/2023572,500 shares $1.05 million -11.9%4.3%9.1 $1.83 10/31/2023649,600 shares $1.29 million +3.0%4.9%12.8 $1.99 10/15/2023630,900 shares $1.10 million -6.0%4.8%10.3 $1.75 9/30/2023670,900 shares $1.61 million -2.8%5.1%9.7 $2.40 9/15/2023690,400 shares $1.76 million -6.0%5.2%6.6 $2.55 8/31/2023734,600 shares $1.95 million -2.6%5.6%5.9 $2.65 8/15/2023754,500 shares $1.97 million -4.9%5.7%4.6 $2.61 7/31/2023793,500 shares $2.20 million +5.6%6.2%4.3 $2.77 7/15/2023751,800 shares $2.29 million -11.6%5.8%3.4 $3.05 6/30/2023850,300 shares $2.17 million +4.7%6.6%3.1 $2.55 6/15/2023811,900 shares $2.58 million -4.7%6.3%1.9 $3.18 5/31/2023851,900 shares $2.56 million -10.5%6.6%2 $3.01 5/15/2023952,200 shares $2.73 million -17.2%7.4%2.3 $2.87 4/30/20231,150,000 shares $2.46 million -4.2%9.2%2.6 $2.14 4/15/20231,200,000 shares $2.35 million -2.4%9.7%2.7 $1.96 3/31/20231,230,000 shares $2.00 million +21.8%9.9%3 $1.63 3/15/20231,010,000 shares $4.19 million +6.4%8.2%4.1 $4.15 2/28/2023949,000 shares $4.27 million +4.9%7.9%4.1 $4.50 2/15/2023904,900 shares $3.92 million +18.8%7.5%3.8 $4.33 1/31/2023761,600 shares $3.52 million +19.6%5.6%2.9 $4.62 1/15/2023636,700 shares $2.73 million +16.5%4.6%0.9 $4.29 12/30/2022546,500 shares $1.50 million -0.1%4.0%0.8 $2.74 12/15/2022547,000 shares $1.53 million -26.2%4.0%0.8 $2.79 11/30/2022740,900 shares $2.04 million -9.7%5.4%1.1 $2.75 11/15/2022820,100 shares $2.15 million +333.2%6.5%1.2 $2.62 10/31/2022189,300 shares $541.40 thousand +68.3%1.5%0.2 $2.86 10/15/2022112,500 shares $441 thousand -91.4%0.9%0.3 $3.92 9/30/20221,310,000 shares $517.58 thousand -10.9%N/A0.3 $0.40 9/15/20221,470,000 shares $707.07 thousand -17.0%N/A0.4 $0.48 8/31/20221,770,000 shares $822.70 thousand +283.0%N/A0.5 $0.46 8/15/2022462,100 shares $596.11 thousand +31.8%N/A0.1 $1.29 7/31/2022350,600 shares $232.59 thousand +57.0%0.7%0.9 $0.66 7/15/2022223,300 shares $145.15 thousand -38.2%0.4%0.6 $0.65 6/30/2022361,100 shares $203.48 thousand -8.3%0.7%1 $0.56 6/15/2022393,800 shares $234.70 thousand +0.8%0.8%1 $0.60 5/31/2022390,700 shares $308.65 thousand -12.8%0.8%0.8 $0.79 5/15/2022448,000 shares $362.88 thousand -35.5%0.9%0.8 $0.81 4/30/2022694,600 shares $632.09 thousand -19.4%1.4%1.1 $0.91 4/15/2022861,800 shares $887.65 thousand -3.5%1.8%1.2 $1.03 3/31/2022892,700 shares $999.82 thousand +4.4%2.0%1.1 $1.12 3/15/2022855,100 shares $701.18 thousand -20.1%1.9%0.8 $0.82 2/28/20221,070,000 shares $930.90 thousand -8.6%2.8%1 $0.87 2/15/20221,170,000 shares $1.23 million +26.4%3.1%1.1 $1.05 1/31/2022925,400 shares $1.12 million +3.5%2.4%0.7 $1.21 1/15/2022894,100 shares $1.32 million +23.9%2.3%0.7 $1.48 12/31/2021721,600 shares $1.05 million -22.0%1.9%0.7 $1.46 12/15/2021925,100 shares $1.63 million -21.6%2.5%1 $1.76 11/30/20211,180,000 shares $2.60 million -4.1%3.2%1.4 $2.20 11/15/20211,230,000 shares $3.51 million +2.5%3.4%1.6 $2.85 10/29/20211,200,000 shares $2.87 million +1.7%3.4%2.8 $2.39 10/15/20211,180,000 shares $2.77 million -33.3%3.4%3 $2.35 9/30/20211,770,000 shares $5.31 million -31.4%5.1%4.6 $3.00 9/15/20212,580,000 shares $7.51 million -2.6%7.4%5.6 $2.91 8/31/20212,650,000 shares $8.48 million -0.8%7.6%5.7 $3.20 8/13/20212,670,000 shares $9.29 million -2.6%7.7%5.5 $3.48 7/30/20212,740,000 shares $9.97 million -9.9%7.9%5.4 $3.64 7/15/20213,040,000 shares $11.83 million +11.8%8.8%5.8 $3.89 6/30/20212,720,000 shares $12.62 million -20.0%7.9%5 $4.64 6/15/20213,400,000 shares $15.16 million +14.9%9.6%7.9 $4.46 5/28/20212,960,000 shares $13.26 million +11.3%8.4%7.1 $4.48 5/14/20212,660,000 shares $11.33 million +11.8%7.6%6 $4.26 4/30/20212,380,000 shares $12.14 million -8.5%7.8%4 $5.10 4/15/20212,600,000 shares $14.59 million +28.1%8.6%3.9 $5.61 3/31/20212,030,000 shares $11.65 million -12.5%6.9%2.7 $5.74 3/15/20212,320,000 shares $16.26 million +9.4%7.9%2.7 $7.01 2/26/20212,120,000 shares $14.37 million -12.4%7.4%2.3 $6.78 2/12/20212,420,000 shares $20.04 million -12.6%8.5%2.5 $8.28 1/29/20212,770,000 shares $16.45 million -9.2%9.5%3.2 $5.94 1/15/20213,050,000 shares $21.75 million -5.0%10.6%3.8 $7.13 12/31/20203,210,000 shares $17.17 million -0.6%10.6%4.2 $5.35 12/15/20203,230,000 shares $19.19 million +1.9%10.7%4.6 $5.94 11/30/20203,170,000 shares $20.16 million +1.3%11.3%4.1 $6.36 10/30/20202,730,000 shares $11.55 million -10.2%10.1%1.8 $4.23 10/15/20203,040,000 shares $11.89 million -8.2%11.4%1.8 $3.91 9/30/20203,310,000 shares $11.45 million -6.0%12.4%2 $3.46 9/15/20203,520,000 shares $12.43 million -1.4%13.2%2.2 $3.53 UBX Short Interest - Frequently Asked Questions What is UNITY Biotechnology's current short interest? Short interest is the volume of UNITY Biotechnology shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 41,000 shares of UBX short. 0.25% of UNITY Biotechnology's shares are currently sold short. Learn More on UNITY Biotechnology's current short interest. Which institutional investors are shorting UNITY Biotechnology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of UNITY Biotechnology: Diadema Partners LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for UNITY Biotechnology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.25% of UNITY Biotechnology's floating shares are currently sold short. Is UNITY Biotechnology's short interest increasing or decreasing? UNITY Biotechnology saw a decrease in short interest in the month of June. As of June 30th, there was short interest totaling 41,000 shares, a decrease of 92.8% from the previous total of 572,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does UNITY Biotechnology's short interest compare to its competitors? 0.25% of UNITY Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to UNITY Biotechnology: HCW Biologics Inc. (2.34%), Bullfrog AI Holdings Inc. (3.94%), IM Cannabis Corp. (0.84%), Marker Therapeutics, Inc. (3.87%), Leap Therapeutics, Inc. (5.18%), Moleculin Biotech, Inc. (11.94%), GeoVax Labs Inc. (20.53%), Flora Growth Corp. (2.38%), BioCardia, Inc. (9.20%), BioVie Inc. (2.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), Strategy Inc ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short UNITY Biotechnology stock? Short selling UBX is an investing strategy that aims to generate trading profit from UNITY Biotechnology as its price is falling. UBX shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against UNITY Biotechnology? A short squeeze for UNITY Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of UBX, which in turn drives the price of the stock up even further. How often is UNITY Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UBX, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies HCW Biologics Short Squeeze Bullfrog AI Short Squeeze IM Cannabis Short Squeeze Marker Therapeutics Short Squeeze Leap Therapeutics Short Squeeze Moleculin Biotech Short Squeeze GeoVax Labs Short Squeeze Flora Growth Short Squeeze BioCardia Short Squeeze BioVie Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:UBX) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding UNITY Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share UNITY Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UBX Stock Alerts